Investigational Drug Details
| Drug ID: | D036 |
| Drug Name: | BI 1467335 |
| Synonyms: | BI467335; BI-467335 |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 71812246 |
| CasNo: | 1478364-68-9 |
| Repositioning for NAFLD: | No |
| SMILES: | Cl.C(=O)(NC(C)(C)C)c1ccc(cc1)OC/C(=C/F)/CN |
| Structure: |
|
| InChiKey: | AEMZEDNMNLIDSL-YGCVIUNWSA-N |
| Molecular Weight: | 316.804 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | AOC3 activator |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 completed (NCT03166735) |
| Latest Progress: | Failed in clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0094 | NCT03166735 | Phase 2 | Completed | Has Results | June 6, 2017 | June 11, 2020 | Details |
| L0556 | EUCTR2016-000499-83-NL | Phase 2 | Not Recruiting | Has Results | 06/03/2017 | 3 November 2020 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|